Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Clinical trial NCT05065177 · COMPLETED
Trial details
- NCT number
- NCT05065177
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 1140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.